PRODUCT PROFILE

Latest Dublin Prices

NAME
LATEST
CHANGE
Aer Lingus 1.98 -0.01 more
BoI 0.32 0.00 more
CRH 19.45 0.10 more
Glanbia 12.85 0.17 more
Greencore 0.64 -0.02 more
Ind. News 0.12 0.01 more
Ryanair 9.64 0.03 more

 

Eli Lilly earnings hit by generic drugs

Tuesday, January 07 12:27:48

U.S. drugmaker Eli Lilly today forecast a decline in earnings this year in line with Wall Street estimates, with results hurt by cheaper generic forms of its Zyprexa schizophrenia drug and Cymbalta depression treatment.

Lilly expects earnings, excluding special items, of $2.77 to $2.85 per share this year. Analysts, on average, expected $2.78 per share, according to Thomson Reuters.